U.S. markets closed

Mesa Laboratories, Inc. (MLAB)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
106.62+4.36 (+4.26%)
Al cierre: 04:00PM EDT
106.62 0.00 (0.00%)
Fuera de horario: 04:02PM EDT

Mesa Laboratories, Inc.

12100 West Sixth Avenue
Lakewood, CO 80228
United States
303 987 8000
https://www.mesalabs.com

Sector(es)Technology
IndustriaScientific & Technical Instruments
Empleados a tiempo completo698

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Gary M. OwensCEO, President & Director1.02MN/D1968
Mr. John V. SakysVP, CFO & Chief Accounting Officer551.4k1.11M1969
Mr. Brian David ArchboldSenior Vice President of Continuous Improvement485.59kN/D1976
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Gestión corporativa

La calificación ISS Governance QuickScore de Mesa Laboratories, Inc. a partir del 1 de abril de 2024 es 5. Las puntuaciones principales son Auditoría: 9; Junta: 4; Derechos del accionista: 3; Compensación: 8.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.